메뉴 건너뛰기




Volumn 361, Issue , 2007, Pages 1-24

Druggable signaling proteins

Author keywords

BCR ABL kinase; EGF receptor; MAP kinases; PKC; Ras proteins; Signaling pathways; STAT proteins

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; TUMOR PROTEIN;

EID: 34948815905     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1385/1-59745-208-4:1     Document Type: Article
Times cited : (17)

References (78)
  • 1
    • 0036490442 scopus 로고    scopus 로고
    • Smart drugs: Tyrosine kinase inhibitors in cancer therapy
    • Shawver, L. K., Slamon, D., and Ullrich, A. (2002) Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1, 117-123.
    • (2002) Cancer Cell , vol.1 , pp. 117-123
    • Shawver, L.K.1    Slamon, D.2    Ullrich, A.3
  • 2
    • 0028000069 scopus 로고
    • Signal-transduction therapy
    • Levitzki, A. (1994) Signal-transduction therapy. Eur. J. Biochem. 226, 1-13.
    • (1994) Eur. J. Biochem , vol.226 , pp. 1-13
    • Levitzki, A.1
  • 3
    • 0032541658 scopus 로고    scopus 로고
    • Cell signaling: An overview
    • Dhanasekaran, N. (1998) Cell signaling: an overview. Oncogene 17, 1329-1330.
    • (1998) Oncogene , vol.17 , pp. 1329-1330
    • Dhanasekaran, N.1
  • 4
    • 0034644539 scopus 로고    scopus 로고
    • Cell signaling by receptor tyrosine kinases
    • Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
    • (2000) Cell , vol.103 , pp. 211-225
    • Schlessinger, J.1
  • 5
    • 0034722889 scopus 로고    scopus 로고
    • The EGF receptor family as targets for cancer therapy
    • Mendelsohn, J. and Baselga, J. (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19, 6550-6565.
    • (2000) Oncogene , vol.19 , pp. 6550-6565
    • Mendelsohn, J.1    Baselga, J.2
  • 8
    • 2442701289 scopus 로고    scopus 로고
    • The ErbB/HER receptor protein-tyrosine kinases and cancer
    • Roskoski, R. (2004) The ErbB/HER receptor protein-tyrosine kinases and cancer. Bioch. Biophys. Res. Commun. 319, 1-11.
    • (2004) Bioch. Biophys. Res. Commun , vol.319 , pp. 1-11
    • Roskoski, R.1
  • 12
    • 0033895709 scopus 로고    scopus 로고
    • Wnt signalling and cancer
    • Polakis, P. (2000) Wnt signalling and cancer. Genes Devel. 14, 1837-1851.
    • (2000) Genes Devel , vol.14 , pp. 1837-1851
    • Polakis, P.1
  • 13
    • 0030592517 scopus 로고    scopus 로고
    • Lessons from hereditary colorectal cancer
    • Kinzler, K. W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170.
    • (1996) Cell , vol.87 , pp. 159-170
    • Kinzler, K.W.1    Vogelstein, B.2
  • 14
    • 0028082161 scopus 로고
    • Protein kinase C - a question of specificity
    • Dekker, L. V. and Parker, P. J. (1994) Protein kinase C - a question of specificity. TIBS 19, 73-77.
    • (1994) TIBS , vol.19 , pp. 73-77
    • Dekker, L.V.1    Parker, P.J.2
  • 15
    • 0027322679 scopus 로고
    • Protein kinase C isoenzymes: Divergence in signal transduction?
    • Hug, H. and Sarre, T. F. (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291, 329-343.
    • (1993) Biochem. J , vol.291 , pp. 329-343
    • Hug, H.1    Sarre, T.F.2
  • 16
    • 0033971901 scopus 로고    scopus 로고
    • Bcl-2 family: Life-or-death switch
    • Tsujimoto, Y. and Shimizu, S. (2000) Bcl-2 family: life-or-death switch. FEBS Letters 466, 6-10.
    • (2000) FEBS Letters , vol.466 , pp. 6-10
    • Tsujimoto, Y.1    Shimizu, S.2
  • 17
    • 0030795866 scopus 로고    scopus 로고
    • Bcl-2 and Bcl-xL can differentially block chemotherapy-induced cell death
    • Simonian, P. L., Grillot, D. A., and Nunez, G. (1997) Bcl-2 and Bcl-xL can differentially block chemotherapy-induced cell death. Blood 90, 1208-1216.
    • (1997) Blood , vol.90 , pp. 1208-1216
    • Simonian, P.L.1    Grillot, D.A.2    Nunez, G.3
  • 18
    • 0028322065 scopus 로고
    • Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
    • Dole, M., Nunez, G., Merchant, A. K., et al. (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54, 3253-3259.
    • (1994) Cancer Res , vol.54 , pp. 3253-3259
    • Dole, M.1    Nunez, G.2    Merchant, A.K.3
  • 19
    • 0035884231 scopus 로고    scopus 로고
    • The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia
    • Arteaga, C. L. (2001) The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J. Clin. Oncol. 19, S32-S40.
    • (2001) J. Clin. Oncol , vol.19
    • Arteaga, C.L.1
  • 21
    • 0035122438 scopus 로고    scopus 로고
    • The value of the human epidermal growth factor receptor-2 (Her-2) as a prognostic marker
    • Cooke, T., Reeves, J., Lannigan, A., and Stanton, P. (2001) The value of the human epidermal growth factor receptor-2 (Her-2) as a prognostic marker. Eur. J. Cancer. 37, 3-10.
    • (2001) Eur. J. Cancer , vol.37 , pp. 3-10
    • Cooke, T.1    Reeves, J.2    Lannigan, A.3    Stanton, P.4
  • 22
    • 1242270613 scopus 로고    scopus 로고
    • The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: A review of preclinical and correlative clinical data
    • Chakravarti, A. Dicker, A., and Mehta, M. (2004) The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data. Int. J. Rad. Oncol. Biol. Phys. 58, 927-931.
    • (2004) Int. J. Rad. Oncol. Biol. Phys , vol.58 , pp. 927-931
    • Chakravarti, A.1    Dicker, A.2    Mehta, M.3
  • 23
    • 0026548240 scopus 로고
    • Structural alterations of the epidermal growth factor receptor gene in human gliomas
    • Wong, A. J., Ruppert, J. M., Bigner, S. H., et al. (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA 89, 2965-2969.
    • (1992) Proc. Natl. Acad. Sci. USA , vol.89 , pp. 2965-2969
    • Wong, A.J.1    Ruppert, J.M.2    Bigner, S.H.3
  • 24
    • 0025313141 scopus 로고
    • Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma
    • Humphrey, P. A., Wong, A. J., Vogelstein, B., et al. (1990) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl. Acad. Sci. USA 87, 4207-4211.
    • (1990) Proc. Natl. Acad. Sci. USA , vol.87 , pp. 4207-4211
    • Humphrey, P.A.1    Wong, A.J.2    Vogelstein, B.3
  • 25
    • 0032875428 scopus 로고    scopus 로고
    • Basic science of HER-2/neu: A Review
    • Hung, M. -C. and Lau, Y. -K. (1999) Basic science of HER-2/neu: A Review. Semin. Oncol. 26, 51-59.
    • (1999) Semin. Oncol , vol.26 , pp. 51-59
    • Hung, M.-C.1    Lau, Y.-K.2
  • 26
    • 0032510109 scopus 로고    scopus 로고
    • Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
    • Amundadottir, L. T. and Leder, P. (1998) Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16, 737-746.
    • (1998) Oncogene , vol.16 , pp. 737-746
    • Amundadottir, L.T.1    Leder, P.2
  • 27
    • 18144399578 scopus 로고    scopus 로고
    • mTOR-targeted therapy of cancer with rapamycin derivatives
    • Vignot, S., Faivre, S., Aguirre, D., and Raymond, E. (2005) mTOR-targeted therapy of cancer with rapamycin derivatives. Ann. Oncol. 16, 525-537.
    • (2005) Ann. Oncol , vol.16 , pp. 525-537
    • Vignot, S.1    Faivre, S.2    Aguirre, D.3    Raymond, E.4
  • 28
    • 1242338152 scopus 로고    scopus 로고
    • The HER receptor family: A rich target for therapeutic development
    • Mass, R. D. (2004) The HER receptor family: a rich target for therapeutic development. Int. J. Rad. Oncol. Biol. Phys. 58, 932-940.
    • (2004) Int. J. Rad. Oncol. Biol. Phys , vol.58 , pp. 932-940
    • Mass, R.D.1
  • 30
    • 0034722887 scopus 로고    scopus 로고
    • Design of growth factor antagonists with antiangiogenic and antitumor properties
    • Sebti, S. M. and Hamilton, A. D. (2000) Design of growth factor antagonists with antiangiogenic and antitumor properties. Oncogene 19, 6566-6573.
    • (2000) Oncogene , vol.19 , pp. 6566-6573
    • Sebti, S.M.1    Hamilton, A.D.2
  • 31
    • 0034670036 scopus 로고    scopus 로고
    • The molecular biology of chronic myeloid leukaemia
    • Deininger, M., Goldman, J., and Melo, J. (2000) The molecular biology of chronic myeloid leukaemia. Blood 96, 3343-3356.
    • (2000) Blood , vol.96 , pp. 3343-3356
    • Deininger, M.1    Goldman, J.2    Melo, J.3
  • 32
    • 0020972981 scopus 로고
    • Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukemia
    • Bartram, C., de Klein, A., and Hagemeijer, A. (1983) Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukemia. Nature 306, 277-280.
    • (1983) Nature , vol.306 , pp. 277-280
    • Bartram, C.1    de Klein, A.2    Hagemeijer, A.3
  • 33
    • 0024376173 scopus 로고
    • Ras oncogenes in human cancer
    • Bos, J. L. (1989) Ras oncogenes in human cancer. Cancer Res. 49, 4682-4689.
    • (1989) Cancer Res , vol.49 , pp. 4682-4689
    • Bos, J.L.1
  • 34
    • 0035908493 scopus 로고    scopus 로고
    • Blocking oncogenic Ras signaling for cancer therapy
    • Adjei, A. A. (2001) Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst. 93, 1062-1074.
    • (2001) J. Natl. Cancer Inst , vol.93 , pp. 1062-1074
    • Adjei, A.A.1
  • 35
    • 0035240617 scopus 로고    scopus 로고
    • Farnesyltransferase inhibitors: A novel targeted therapy for cancer
    • Johnston, S. R. (2001) Farnesyltransferase inhibitors: a novel targeted therapy for cancer. Lancet Oncol. 2, 18-26.
    • (2001) Lancet Oncol , vol.2 , pp. 18-26
    • Johnston, S.R.1
  • 36
    • 0036031772 scopus 로고    scopus 로고
    • Therapeutics targeting signal transduction for patients with colorectal carcinoma
    • De Bono, J. S. and Rowinsky, E. K. (2002) Therapeutics targeting signal transduction for patients with colorectal carcinoma. Br. Med. Bulletin. 64, 227-254.
    • (2002) Br. Med. Bulletin , vol.64 , pp. 227-254
    • De Bono, J.S.1    Rowinsky, E.K.2
  • 37
    • 0030838791 scopus 로고    scopus 로고
    • In vitro and in vivo activity of antisense inhibitors of ras: Potential for clinical development
    • Cowsert, L. M. (1997) In vitro and in vivo activity of antisense inhibitors of ras: potential for clinical development. Anticancer Drug. Des. 12, 359-371.
    • (1997) Anticancer Drug. Des , vol.12 , pp. 359-371
    • Cowsert, L.M.1
  • 38
    • 0026774939 scopus 로고
    • Selective inhibition of mutant Ha-Ras mRNA expression by antisense oligonucleotides
    • Monia, B. P., Ecker, D. J., Zounes, M. A., Lima, W. F., and Freier, S. M. (1992) Selective inhibition of mutant Ha-Ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267, 19,954-19,962.
    • (1992) J. Biol. Chem , vol.267
    • Monia, B.P.1    Ecker, D.J.2    Zounes, M.A.3    Lima, W.F.4    Freier, S.M.5
  • 40
    • 0024583137 scopus 로고
    • Loss of heterozygosity of the c-raf locus in small cell lung carcionoma
    • Sithanandam, G., Dean, M., Brennscheidt, U., et al. (1989) Loss of heterozygosity of the c-raf locus in small cell lung carcionoma. Oncogene 4, 451-455.
    • (1989) Oncogene , vol.4 , pp. 451-455
    • Sithanandam, G.1    Dean, M.2    Brennscheidt, U.3
  • 42
    • 0027996763 scopus 로고
    • Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: Reconstitution of the signalling pathway in vitro
    • Marquardt, B., Frith, D., and Stabel, S. (1994) Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9, 3213-3218.
    • (1994) Oncogene , vol.9 , pp. 3213-3218
    • Marquardt, B.1    Frith, D.2    Stabel, S.3
  • 44
    • 0036624790 scopus 로고    scopus 로고
    • Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
    • Iversen, P. O., Emanuel, P. D., and Sioud, M. (2002) Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth. Blood 99, 4147-4153.
    • (2002) Blood , vol.99 , pp. 4147-4153
    • Iversen, P.O.1    Emanuel, P.D.2    Sioud, M.3
  • 45
    • 0029977448 scopus 로고    scopus 로고
    • Antitumor activity of phosphorothioate antisense oligodeoxynucleotide targeted against c-Raf kinase
    • Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., and Fabbro, D. (1996) Antitumor activity of phosphorothioate antisense oligodeoxynucleotide targeted against c-Raf kinase. Nat. Med. 2, 668-675.
    • (1996) Nat. Med , vol.2 , pp. 668-675
    • Monia, B.P.1    Johnston, J.F.2    Geiger, T.3    Muller, M.4    Fabbro, D.5
  • 46
    • 0034722894 scopus 로고    scopus 로고
    • Development of anticancer drugs targeting the MAP kinase pathway
    • Sebolt-Leopold, J. S. (2000) Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19, 6594-6599.
    • (2000) Oncogene , vol.19 , pp. 6594-6599
    • Sebolt-Leopold, J.S.1
  • 48
    • 0032984348 scopus 로고    scopus 로고
    • Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
    • Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., et al. (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5, 810-816.
    • (1999) Nat. Med , vol.5 , pp. 810-816
    • Sebolt-Leopold, J.S.1    Dudley, D.T.2    Herrera, R.3
  • 49
    • 0032935664 scopus 로고    scopus 로고
    • Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
    • Schaeffer, H. J. and Weber, M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444.
    • (1999) Mol. Cell. Biol , vol.19 , pp. 2435-2444
    • Schaeffer, H.J.1    Weber, M.J.2
  • 50
    • 0025823448 scopus 로고
    • ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin
    • Boulton, G., Nye, S. H., Robbibs, D. J., et al. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin. Cell 65, 663-675.
    • (1991) Cell , vol.65 , pp. 663-675
    • Boulton, G.1    Nye, S.H.2    Robbibs, D.J.3
  • 51
    • 0033545565 scopus 로고    scopus 로고
    • Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells
    • Plattner, R., Gupta, S., Khosravi-Far, R., et al. (1999) Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Oncogene 18, 1807-1817.
    • (1999) Oncogene , vol.18 , pp. 1807-1817
    • Plattner, R.1    Gupta, S.2    Khosravi-Far, R.3
  • 52
    • 0034648695 scopus 로고    scopus 로고
    • Interference with the constitutive activation of ERKl and ERK2 impairs EWS/FLI-1-dependent transformation
    • Silvany, R. E., Eliazer, S., Wolff, N. C., and Ilaria, R. L., Jr. (2000) Interference with the constitutive activation of ERKl and ERK2 impairs EWS/FLI-1-dependent transformation. Oncogene 19, 4523-4530.
    • (2000) Oncogene , vol.19 , pp. 4523-4530
    • Silvany, R.E.1    Eliazer, S.2    Wolff, N.C.3    Ilaria Jr., R.L.4
  • 53
    • 0027742729 scopus 로고
    • Interferoninduced nuclear signaling by Jak protein tyrosine kinases
    • Silvennoinen, O., Ihle, J. N., Schlessinger, J., and Levy, D. E. (1993) Interferoninduced nuclear signaling by Jak protein tyrosine kinases. Nature 366, 583-585.
    • (1993) Nature , vol.366 , pp. 583-585
    • Silvennoinen, O.1    Ihle, J.N.2    Schlessinger, J.3    Levy, D.E.4
  • 54
    • 0036233585 scopus 로고    scopus 로고
    • Cytokine signaling in 2002: New surprises in the JAK/STAT pathway
    • O'Shea, J. J., Gadina, M., and Schreiber, R. D. (2002) Cytokine signaling in 2002: new surprises in the JAK/STAT pathway. Cell 109, S121-S131.
    • (2002) Cell , vol.109
    • O'Shea, J.J.1    Gadina, M.2    Schreiber, R.D.3
  • 55
    • 0036256836 scopus 로고    scopus 로고
    • JAK-STAT signaling in human disease
    • Schindler, C. W. (2002) JAK-STAT signaling in human disease. J. Clin. Invest. 109, 1133-1137.
    • (2002) J. Clin. Invest , vol.109 , pp. 1133-1137
    • Schindler, C.W.1
  • 57
    • 1542327277 scopus 로고    scopus 로고
    • Inhibitors of JAKs/STATs and the kinases: A possible new cluster of drugs
    • Luo, C. and Laaja, P. (2004) Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs. DDT 9, 268-275.
    • (2004) DDT , vol.9 , pp. 268-275
    • Luo, C.1    Laaja, P.2
  • 59
    • 0034722896 scopus 로고    scopus 로고
    • STAT proteins: Novel molecular targets for cancer drug discovery
    • Turkson, J. and Jove, R. (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19, 6613-6626.
    • (2000) Oncogene , vol.19 , pp. 6613-6626
    • Turkson, J.1    Jove, R.2
  • 60
    • 0242285719 scopus 로고    scopus 로고
    • STAT proteins: From normal control of cellular events to tumorigenesis
    • Calo, V., Migliavacca, M., Bazan, V., et al. (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197, 157-168.
    • (2003) J. Cell. Physiol , vol.197 , pp. 157-168
    • Calo, V.1    Migliavacca, M.2    Bazan, V.3
  • 61
    • 0035977055 scopus 로고    scopus 로고
    • Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation, and cell transformation
    • Turkson, J., Ryan, D., Kim, J. S., et al. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation, and cell transformation. /. Biol. Chem. 276, 45,443-45,455.
    • (2001) Biol. Chem , vol.276
    • Turkson, J.1    Ryan, D.2    Kim, J.S.3
  • 62
    • 0026451081 scopus 로고
    • Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
    • Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614.
    • (1992) Science , vol.258 , pp. 607-614
    • Nishizuka, Y.1
  • 63
    • 0020634260 scopus 로고
    • Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters
    • Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., and Nishizuka, Y. (1983) Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem. 258, 11,442-11,445.
    • (1983) J. Biol. Chem , vol.258
    • Kikkawa, U.1    Takai, Y.2    Tanaka, Y.3    Miyake, R.4    Nishizuka, Y.5
  • 64
    • 0023880172 scopus 로고
    • Protein kinase C as the receptor for the phorbol ester tumor promoters: Sixth roads memorial award lecture
    • Blumberg, P. M. (1988) Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth roads memorial award lecture. Cancer Res. 48, 1-8.
    • (1988) Cancer Res , vol.48 , pp. 1-8
    • Blumberg, P.M.1
  • 65
    • 0036177115 scopus 로고    scopus 로고
    • Targeting protein kinase C: New terapeutic opportunities against high-grade malignant gliomas
    • Rocha, A. B., Mans, D. R. A., Regner, A., and Schwartsmann, G. (2002) Targeting protein kinase C: new terapeutic opportunities against high-grade malignant gliomas. The Oncologist 7, 17-33.
    • (2002) The Oncologist , vol.7 , pp. 17-33
    • Rocha, A.B.1    Mans, D.R.A.2    Regner, A.3    Schwartsmann, G.4
  • 66
    • 0031864708 scopus 로고    scopus 로고
    • A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth
    • Sioud, M. and Sørensen, D. R. (1998) A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth. Nat. Biotechnol. 16, 556-561.
    • (1998) Nat. Biotechnol , vol.16 , pp. 556-561
    • Sioud, M.1    Sørensen, D.R.2
  • 67
    • 0032990503 scopus 로고    scopus 로고
    • Ribozyme inhinition of the protein kinase Ca triggers apoptosis in glioma cells
    • Leirdal, M. and Sioud, M. (1999) Ribozyme inhinition of the protein kinase Ca triggers apoptosis in glioma cells. Br. J. Cancer. 80, 1558-1564.
    • (1999) Br. J. Cancer , vol.80 , pp. 1558-1564
    • Leirdal, M.1    Sioud, M.2
  • 68
    • 0034711950 scopus 로고    scopus 로고
    • Design of nuclease resistant protein kinase Ca DNA enzymes with potential therapeutic application
    • Sioud, M. and Leirdal, M. (2000) Design of nuclease resistant protein kinase Ca DNA enzymes with potential therapeutic application. J. Mol. Biol. 296, 937-947.
    • (2000) J. Mol. Biol , vol.296 , pp. 937-947
    • Sioud, M.1    Leirdal, M.2
  • 69
    • 0031963427 scopus 로고    scopus 로고
    • Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice
    • Geiger, T., Muller, M., Dean, N. M., and Fabbro, D. (1998) Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anticancer Drug Des. 13, 35-45.
    • (1998) Anticancer Drug Des , vol.13 , pp. 35-45
    • Geiger, T.1    Muller, M.2    Dean, N.M.3    Fabbro, D.4
  • 70
    • 0032409781 scopus 로고    scopus 로고
    • Bcl-2 family proteins
    • Reed, J. C. (1998) Bcl-2 family proteins. Oncogene 17, 3225-3236.
    • (1998) Oncogene , vol.17 , pp. 3225-3236
    • Reed, J.C.1
  • 71
    • 0032580361 scopus 로고    scopus 로고
    • Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
    • Zamzami, N., Brenner, C., Marzo, I., Susin, S. A., and Kroemer, G. (1998) Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16, 2265-2282.
    • (1998) Oncogene , vol.16 , pp. 2265-2282
    • Zamzami, N.1    Brenner, C.2    Marzo, I.3    Susin, S.A.4    Kroemer, G.5
  • 72
    • 5244224827 scopus 로고    scopus 로고
    • X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
    • Muchmore, S. W., Sattler, M., Liang, H., et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death Nature 381, 335-341.
    • (1996) Nature , vol.381 , pp. 335-341
    • Muchmore, S.W.1    Sattler, M.2    Liang, H.3
  • 73
    • 20444486559 scopus 로고    scopus 로고
    • An inhibitor of Bcl-2 family proteins induces regression of solid tumours
    • Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677-681.
    • (2005) Nature , vol.435 , pp. 677-681
    • Oltersdorf, T.1    Elmore, S.W.2    Shoemaker, A.R.3
  • 74
    • 0030807543 scopus 로고    scopus 로고
    • A novel antisense oligonucleotide targeting the coding region of the bcl-2 mRNA is a potent inducer of apoptosis in small cell lung cancer cells
    • Ziegler, A., Luedke, G. H., Fabbro, D., Altmann, K. H., Stahel, R. A., and Zangemeister-Wittke, U. (1997) A novel antisense oligonucleotide targeting the coding region of the bcl-2 mRNA is a potent inducer of apoptosis in small cell lung cancer cells. J. Natl. Cancer Inst. 89, 1027-1036.
    • (1997) J. Natl. Cancer Inst , vol.89 , pp. 1027-1036
    • Ziegler, A.1    Luedke, G.H.2    Fabbro, D.3    Altmann, K.H.4    Stahel, R.A.5    Zangemeister-Wittke, U.6
  • 75
    • 0034071150 scopus 로고    scopus 로고
    • Induction of apoptosis in lung cancer cells following bcl-xL antisense treatment
    • Leech, S. H., Olie, R. A., Gautschi, O., et al. (2000) Induction of apoptosis in lung cancer cells following bcl-xL antisense treatment. Int. J. Cancer. 86, 570-576.
    • (2000) Int. J. Cancer , vol.86 , pp. 570-576
    • Leech, S.H.1    Olie, R.A.2    Gautschi, O.3
  • 76
    • 0036830417 scopus 로고    scopus 로고
    • Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphoamide
    • Simoes-Wust, A., Schurpf, T., Hall, J., Stahel, R. A., and Zangmeister-wittke, U. (2002) Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphoamide. Breast. Cancer. Res. Treat. 76, 157-166.
    • (2002) Breast. Cancer. Res. Treat , vol.76 , pp. 157-166
    • Simoes-Wust, A.1    Schurpf, T.2    Hall, J.3    Stahel, R.A.4    Zangmeister-wittke, U.5
  • 77
    • 0035902141 scopus 로고    scopus 로고
    • The microenvironment of the tumour-host interface
    • Liotta, L. A. and Kohn, E. C. (2001) The microenvironment of the tumour-host interface. Nature 411, 375-379.
    • (2001) Nature , vol.411 , pp. 375-379
    • Liotta, L.A.1    Kohn, E.C.2
  • 78
    • 3442901908 scopus 로고    scopus 로고
    • Colony-stimulating factor-1 blockage by antisense oligonucleotides and small-interfering RNAs suppresses growth of human mammary tumor xenografts in mice
    • Aharinejad, S., Paulus, P., Sioud, M., et al. (2004) Colony-stimulating factor-1 blockage by antisense oligonucleotides and small-interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Caner Res. 64, 5378-5384.
    • (2004) Caner Res , vol.64 , pp. 5378-5384
    • Aharinejad, S.1    Paulus, P.2    Sioud, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.